Rady Children's Specialists of San Diego

Medical Group / IPA


Medical School

UC San Diego


UC San Diego


UC San Diego


UC San Diego

Board Certifications





Dr. Dawn Eichenfield is a dermatologist at Rady Children's Hospital-San Diego and an assistant clinical professor of dermatology at UC San Diego School of Medicine.

Dr. Eichenfield graduated from the Massachusetts Institute of Technology, where she studied biology and psychology, and conducted both immunology and bioengineering research. She then completed a combined M.D. and Ph.D. training program at UC San Diego, where her research garnered multiple awards and publications in prestigious journals. During her residency, Dr. Eichenfield served as chief resident; she went on to complete her fellowship in pediatric dermatology at Rady Children's.

Dr. Eichenfield works to advance clinical and translational research through studies focusing on laser medicine and pediatric dermatology. Along with laser surgery, her clinical interests include dermatologic surgery, genetics, birthmarks, vascular skin disorders, acne, warts, molluscum, atopic dermatitis (eczema) and other inflammatory disorders. She is involved in the multidisciplinary Vascular Lesions Clinic and follows patients for their dermatologic concerns.

Dr. Eichenfield hopes that her unique background will allow her to offer her patients the most advanced and personalized skin care treatments.

In her free time, she enjoys hiking, traveling, cooking and reading with her husband and two daughters.

See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine. PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.


Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination.
Ikediobi O, Eichenfield DZ, Barrio VR

Management of Acne Vulgaris: A Review.
Eichenfield DZ, Sprague J, Eichenfield LF

Crusted Papules on the Bilateral Helices and Lobules.
Eichenfield DZ, Hinds B, Schneider J

Increased Risk of Cutaneous Diseases in Multiple Myeloma Patients.
Buntinx-Krieg T, McKee RM, Eichenfield DZ, Marsch A

Nevoid melanoma and eruptive nevi from erlotinib.
Seidman JS, Eichenfield DZ, Orme CM

Efficacy and Safety of the 532-nm KTP and Long-Pulsed 1064-nm Neodymium-doped Yttrium Aluminum Garnet Laser for Treatment of Vascular Malformations.
Eichenfield DZ, Ortiz AE

Dupilumab for bullous pemphigoid with intractable pruritus.
Seidman JS, Eichenfield DZ, Orme CM

Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum.
Chen SX, Eichenfield DZ, Orme C, Hinds B

Evidence-based skin care in preterm infants.
Kusari A, Han AM, Virgen CA, Matiz C, Rasmussen M, Friedlander SF, Eichenfield DZ

Agminated blue nevus with a GNAQ mutation: A case report and review of the literature.
Eichenfield DZ, Cotter D, Thorson J, Hinds B, Sun BK

Tissue damage drives co-localization of NF-κB, Smad3, and Nrf2 to direct Rev-erb sensitive wound repair in mouse macrophages.
Eichenfield DZ, Troutman TD, Link VM, Lam MT, Cho H, Gosselin D, Spann NJ, Lesch HP, Tao J, Muto J, Gallo RL, Evans RM, Glass CK

Amitriptyline-induced cutaneous hyperpigmentation: case report and review of psychotropic drug-associated mucocutaneous hyperpigmentation.
Eichenfield DZ, Cohen PR

Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 1: overview, clinical characteristics, and laboratory evaluation.
Del Rosso JQ, Harper JC, Graber EM, Thiboutot D, Silverberg NB, Eichenfield DZ, Eichenfield LF

Pimecrolimus is safe and effective in treating atopic dermatitis.
Eichenfield DZ, Eichenfield LF

Environment drives selection and function of enhancers controlling tissue-specific macrophage identities.
Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, Stender JD, Chun HB, Garner H, Geissmann F, Glass CK

Towards an understanding of cell-specific functions of signal-dependent transcription factors.
Zhang DX, Glass CK

Pharmacological inhibition of the ClpXP protease increases bacterial susceptibility to host cathelicidin antimicrobial peptides and cell envelope-active antibiotics.
McGillivray SM, Tran DN, Ramadoss NS, Alumasa JN, Okumura CY, Sakoulas G, Vaughn MM, Zhang DX, Keiler KC, Nizet V

Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.
Huang W, Ghisletti S, Saijo K, Gandhi M, Aouadi M, Tesz GJ, Zhang DX, Yao J, Czech MP, Goode BL, Rosenfeld MG, Glass CK

ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracis.
McGillivray SM, Ebrahimi CM, Fisher N, Sabet M, Zhang DX, Chen Y, Haste NM, Aroian RV, Gallo RL, Guiney DG, Friedlander AM, Koehler TM, Nizet V

See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.

PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.

Rady Children's updates the Doctor Finder annually. We are not responsible for omissions or errors. Prior to making an appointment, please be sure to check with your health plan to confirm coverage. If you see an error or omission on a physician's profile page, please contact us at refsvc@rchsd.org.